β-HCG has been the only tumor marker evaluated in testicular vein (VT) blood until now.
To evaluate the correlation between the tumor markers β-HCG, AFP, PLAP, and LDH from the VT and peripheral blood as well as their significance in predicting tumor recurrence and tumor stage.